Cancer Prevention & Screening Information for Healthcare Providers

Important Documents

BreastCheck, CervixCheck and ColonCheck are the population-based screening programs operated by CancerCare Manitoba. Our goal is to reduce the rates of incidence and mortality from breast, cervical and colon cancers by screening eligible Manitobans at intervals that maximize the benefit and minimize the potential harms of each screening test. To read more about us, click here.

News

Effective April 19, 2022: Implementation of colonoscopy waitlist reduction project and new fecal occult blood test (FOBT) requisition form

Reducing Colonoscopy Waitlist Project

In support of reducing the endoscopy waitlist, ColonCheck CancerCare Manitoba will be distributing fecal immunochemical tests (FIT) to consenting eligible patients currently on the elective colonoscopy waitlist. This includes patients at average risk and selected patients at increased risk due to family history or surveillance of prior low-risk adenomas. This project provides an interim option for FIT until the transition from gFOBT to full FIT implementation has occurred.

Fecal Occult Blood Test Requisition

Healthcare Providers can access FOBTs for their patients using the FOBT requisition form. ColonCheck CancerCare Manitoba will supply the appropriate test kit based on the following criteria:

  • Guaiac FOBT (gFOBT) for average risk colorectal cancer screening for patients age 50 years and older
  • FIT for selected low increased risk colorectal cancer screening as an alternative to colonoscopy
  • FIT for low risk adenoma surveillance as an alternative to colonoscopy

For more information and to access the forms click here.

Background Information:

Shared Health Diagnostic Services, Dynacare and CancerCare Manitoba are introducing HPV reflex testing to Manitoba. The new process is called HPV reflex testing (also known as HPV triage). HPV reflex testing is used to detect high-risk human papillomavirus (hrHPV) on certain Pap tests to determine which patients require colposcopy versus those who can return to routine screening.  

Clinical Practice Change:

Effective March 14, 2022 cervical cytology labs in Manitoba will automatically perform high-risk human papillomavirus testing on the Pap test specimens of patients:

  • 30 years of age and older with Atypical Squamous Cells of Undetermined Significance (ASCUS) Pap test results, or
  • 50 years of age and older with Low-Grade Squamous Intraepithelial Lesion (LSIL) Pap test results.

Providers will receive one cervical cancer screening lab report with both the cytological interpretation and the
high-risk HPV test result.

  • Patients with hrHPV POSITIVE test results should be referred to colposcopy.
  • Patients with hrHPV NEGATIVE test results should return to routine screening with Pap tests.
  • Patients with hrHPV INVALID test results should have a repeat Pap test in six months.

Clinical Practice Change (pdf) 

As of January 2021, BreastCheck will include the mammogram result, breast density category using BI-RADS, and breast cancer risk reduction information in result letters to patients and their healthcare providers.

Review BreastCheck Results: Patient Discussion Guide (pdf), Talking To Your Patients About Breast Density and Breast Cancer Risk (webinar)

CancerCare Manitoba Prevention & Screening is recruiting interested, enthusiastic health promotion champions in primary care to participate on an advisory committee. The purpose of the committee is to facilitate ongoing reciprocal communication between healthcare providers and CancerCare Manitoba Prevention & Screening in order to generate feedback and input into projects, resources and activities. To learn more, click here.

Program Operations

BreastCheck, CervixCheck, and ColonCheck operate population-based registries which allow us to:

  • identify individuals eligible for cancer screening,
  • send letters of invite, recall, reminder and result notification,
  • monitor data, and
  • evaluate program operations.

Invitation strategies used include:

  • direct mail,
  • collaborating with healthcare providers, and
  • health promotion activities.

Each program sends a variety of letter types on a pre-determined timeline.

TYPE DESCRIPTION BREAST CERVIX COLON
NOTIFY Advise eligible individual that they will receive a test unless they contact the screening program     checkmark
INVITE Encourage eligible individual to participate in screening for the first time checkmark checkmark checkmark
RECALL Invite an eligible individual to participate in screening at the recommended interval checkmark checkmark checkmark
REMIND Sent after the initial invite to the eligible individual as a reminder to do the test checkmark checkmark checkmark
RESULT* Inform an individual of their screening test result. checkmark checkmark checkmark

*CervixCheck will send a result letter to a patient if they have a high-grade abnormal result or if the patient does not have appropriate follow-up listed in the CervixCheck registry.

For more information on each program's correspondence pathway, click below:

BreastCheck (pdf) | CervixCheck (pdf) | ColonCheck (pdf)

 

The CancerCare Manitoba Screening Programs have a team of Health Educators that plan, implement, and evaluate various education and health promotion activities for the public and providers on breast, cervical and colon cancer screening. Click below to:

Reports

BreastCheck

Participation Rates by Community (pdf)

2015 | 2014 | 2013 | 2012

Participation Rates by RHA (pdf)

Northern Burntwood 2014 | 2013 | 2012
Northern Norman 2014 | 2013 | 2012
Southern Central 2014 | 2013 | 2012
Southern South Eastman 2014 | 2013 | 2012
Interlake-Eastern Interlake 2014 | 2013 | 2012
Interlake-Eastern North Eastman 2014 | 2013 | 2012
Prairie Mountain Assiniboine 2014 | 2013 | 2012
Prairie Mountain Parkland 2014 | 2013 | 2012

Winnipeg 2014 | 2013 | 2012
Brandon 2014 | 2013 | 2012

Contact

CancerCare Manitoba
Screening Programs
#5-25 Sherbrook Street
Winnipeg, MB, R3C 2B1
Screening@cancercare.mb.ca
1-855-95-CHECK